LLY compared with ARCT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ARCTArcturus Therapeutics Holdings Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ARCTArcturus Therapeutics Holdings Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ARCT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±16.3%▲+10.58%×0.65

Q2 FY26±21.8%▲+21.88%×1.00

= impliedLLY realized, solidARCT realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

May 8 '26

±15.5%

▲+3.60%

×0.23

Q1 FY26±18.3%▼−4.17%×0.23

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ARCTArcturus Therapeutics Holdings Inc.

10.36▲+10.67%· post 10.36

ClosedNov 6 '26

Mkt cap$298.3MRevenue$18MQ3 FY26Revenue$82MFY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

ARCTArcturus Therapeutics Holdings Inc.

1,360.90▼−0.28%post 1,358.90

Price

10.36▲+10.67%post 10.36

$1.2T

Mkt cap

$298.3M

Q3 FY26$24.4B

Revenue

$18MQ3 FY26

FY25$65.2B

Revenue

$82MFY25

LLY1,360.90▼−0.28%vsARCT10.36▲+10.67%ClosedNov 6 '26